• Home
• Reports
• Companies

• Partnering Search
• Profiling
• PL Intelligence

• Out-licensing
• In-licensing
• Services

• Deals review
• Industry news
• Press releases

• Events
• Articles
• Newsletter

Report search

Enter your keyword(s) (company name, disease target, therapeutic category, industry sector) into the search box and hit the search button to return reports matching your interests.

Searches on wide topic areas may take a moment to display, please be patient. If you have any queries about the report searching please contact us.

Latest Market Research Reports

Worldwide Biotech - July 2009
Worldwide Biotech provides news and information on biotechnology as an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry.

Latvia Pharmaceuticals and Healthcare Report Q3 2009
BMI calculates the Latvian pharmaceutical market to have been worth LVL256mn (US$512mn) in 2008,and by 2013, drug expenditure is expected to reach a value of LVL352mn. In US dollar terms, however,as a result of the weakening lat, drug market spending will fall to US$428mn in 2009, before rising againto US$482mn in 2013 (a figure below the 2008 market value).In BMI’s Business...

Zimbabwe Pharmaceuticals and Healthcare Report Q3 2009
In the BMI Business Environment Ranking for Q309, Zimbabwe remains firmly at the bottom of thematrix, which ranks 17 key markets surveyed in the Middle East and Africa (MEA) region, as well asglobally. Zimbabwe’s position is expected to show little improvement over the coming months, as thegovernment continues to struggle with economic and political issues, which have sidelined health in...

Slovakia Pharmaceuticals and Healthcare Report Q3 2009
Following an update to our macroeconomic variables as a result of both the eurozone accession andglobal economic downturn, BMI now expects Slovakia’s pharmaceutical expenditure to grow toEUR2.06bn (US$2.62bn) by 2013. While this is below our previous expectations, it still represents ahealthy compound annual growth rate (CAGR) of 8.9% over the forecast period.However, the...

Kuwait Pharmaceuticals and Healthcare Report Q3 2009
Kuwait’s pharmaceutical market is small in regional terms. Combined sales of over-the-counter (OTC)and prescription drugs reached a total of US$377mn in 2008, and we expect this to reach US$462mn by2013 - representing a compound annual growth rate (CAGR) of 4.17% in US dollar terms.Pharmaceutical spending will account for 0.27% of GDP, with per capita expenditure at US$136 by theend of the...

Reports on Bigpharma

Reports on Therapeutic Sector